All Voices
Physician· Evidence Review

Peter Attia

Longevity medicine's most rigorous physician

Last reviewed: March 30, 2026Topics: Longevity Medicine, Cardiovascular Risk, Exercise, Zone 2 Training
Peter Attia photographed in 2025.
Photo: Jop van Velthuis / Wikimedia Commons, CC BY-SA 4.0 · source · 2025

Bio

Peter Attia is a Stanford-trained physician who pioneered a 'Medicine 3.0' approach focused on preventing the chronic diseases that kill most people — cardiovascular disease, cancer, neurodegeneration, and type 2 diabetes — decades before they manifest. His 2023 book Outlive became a New York Times bestseller and helped bring longevity medicine into the mainstream.

Background

Attia trained as a general surgeon at Johns Hopkins and completed fellowship work at the NIH National Cancer Institute. He left academic medicine to work at McKinsey & Company, then returned to clinical practice focused exclusively on longevity and performance medicine. His practice, Early Medical, is a concierge service for a small number of patients with a waiting list of several years.

What They Do

Attia's approach centers on four categories of intervention: exercise (particularly Zone 2 cardio and strength training), nutrition (flexible, protein-focused), sleep, and emotional health. He is unusually rigorous about citing primary literature, admitting uncertainty, and updating his views when new evidence emerges. His podcast features multi-hour interviews with leading researchers. He is also a prolific commentator on ApoB and cardiovascular risk management.

Research Record

Attia has several peer-reviewed publications from his NIH years in surgical oncology, but he does not run a research lab and has not published primary longevity research. His contribution to the field is synthesis, education, and clinical translation — not bench science.

Our Evidence Summary

Of the three voices on this page, Attia's recommendations are the most evidence-aligned. He consistently distinguishes between well-supported interventions (exercise, sleep, cardiovascular risk reduction) and speculative ones (rapamycin, senolytics). His framework around 'the four horsemen' of chronic disease is clinically sensible. Critiques focus on the accessibility of his approach (concierge medicine, expensive testing) rather than the underlying science.

Claim-by-Claim Evidence Review

Strong Evidence

Zone 2 cardiovascular training improves mitochondrial function and metabolic health

Exercise physiology research consistently shows Zone 2 training increases mitochondrial density and fat oxidation. The specific '4x45 min/week' protocol is a reasonable synthesis of the evidence.

Strong Evidence

Grip strength and VO2 max are strong predictors of all-cause mortality

Multiple large cohort studies (Copenhagen Male Study, cardiorespiratory fitness meta-analyses) show VO2 max is one of the strongest predictors of longevity — more predictive than smoking status.

Strong Evidence

ApoB is a better marker of cardiovascular risk than LDL-C

Emerging consensus in lipidology. ApoB counts the actual number of atherogenic particles, which is a more direct measure of risk than LDL cholesterol concentration.

Strong Evidence

Aggressive early lipid-lowering (statins, PCSK9 inhibitors) prevents cardiovascular disease

One of the most robustly evidence-backed interventions in all of medicine. Attia's 'ApoB under 60 mg/dL' target is at the aggressive end but well within guideline-supported territory for high-risk patients.

Speculative

Rapamycin can extend human lifespan

Rapamycin extends lifespan in mice robustly. Human data is limited to small trials with surrogate endpoints. Attia discusses this honestly as off-label and experimental, which is the right framing.

Strong Evidence

Strength training prevents frailty and extends independent lifespan

Sarcopenia (muscle loss) is one of the clearest causes of age-related disability. Resistance training is the most effective intervention — clinical guidelines universally recommend it.

Limited Evidence

Continuous glucose monitoring improves metabolic health in non-diabetics

Intuitive and increasingly popular, but randomized trial evidence in healthy adults is thin. Attia himself has updated his views on this, which is a credit to him.

Related Reading

Editorial note: This page evaluates the public claims and protocols of a third party. We do not receive compensation from any of the people profiled and have no affiliation with them. Evidence levels are assigned by reviewing primary literature and reflect the state of the science as of March 2026. Science evolves — we update these reviews when new evidence emerges. This is not medical advice; consult a qualified physician before changing your health practices.